Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Timothy Squire Toronto Lawyer

Timothy M. Squire

Partner Fasken
Increasing government regulation continues to put more pressure on the life sciences sector in Canada.
Jurisdiction Ontario, 1997
Language(s) English
Office(s) Toronto
Contact

Timothy Squire is one of Canada's leading Life Sciences Industry Specialists. With his extensive regulatory and commercialization experience, Tim has become a trusted advisor to stakeholders in the drug, medical device, natural health product, cosmetic and food industries in Canada and from around the world.

Tim’s practice is devoted to the Life Sciences industry, and he is the former Chair of the firm's International Life Sciences Industry Group. He adds substantial bench strength given his extensive knowledge and experience across the entire health product lifecycle. Tim has become a trusted advisor to many stakeholders in the drug, medical device, natural health product, cosmetic and food industries in Canada and around the world due to his expertise and commitment to client service.

Tim's regulatory practice covers all aspects of health product regulation and market access, and he is one of the few specialists in Canada regularly called upon to help solve complex health product compliance and enforcement issues. To this end, Tim frequently communicates with Health Canada and other federal and provincial regulators on our clients’ behalf.  

In addition to his regulatory expertise, Tim also negotiates and drafts sophisticated commercial arrangements for Life Sciences clients, including license agreements, distribution agreements, manufacturing and supply agreements, quality and pharmacovigilance agreements, technology and material transfer agreements, joint R&D agreements, and funding agreements.

Tim also quarterbacks regulatory due diligence in complex domestic and cross-border transactions involving drug, medical device, natural health product, cosmetic, and food companies, and is often called upon to manage post-closing integration, including the transition of market authorizations and regulatory operations.

Tim performs in-house legal functions for several U.S. and international clients without Canadian in-house legal or regulatory capabilities, and in this capacity has developed a comprehensive understanding of the business issues and pressures facing companies in the life sciences industry.

Tim’s expertise in the life sciences sector has been recognized by Chambers Canada, Who’s Who Legal, IAM Strategy 300: The World’s Leading IP Strategists, and he has twice received LMG’s Life Sciences Canadian Regulatory Attorney of the Year award.

  • Recognized nationwide in Life Sciences , Chambers Canada 2017 to 2020
  • The World's Leading IP Strategists, IAM Strategy 300 2018
  • Recognized for Life Sciences, Who's Who Legal Canada 2014 to 2018
Chambers Canada Recognized nationwide in Life Sciences Chambers Canada covers lawyers and law firms practicing in all provinces and territories in Canada.
2018 IAM Strategy 300 The World's Leading IP Strategists
2014 to 2018 Who's Who Legal Canada Recognized for Life Sciences
Date

Education

  • LLB University of Windsor
  • BA University of Windsor
Article, Co-Author When is Software a Medical Device? Electronic Healthcare Law Review, LexisNexis, Volume 8, No. 4, May 2019, pages 44-45
Article Canadian Expert Tim Squire: Bill pushing drug imports from Canada is a roundabout solution Stat News
Article U.S. Bill to Import Canadian Drugs Gets Chilly Reception North of the Border International Trade Reporter

    Subscribe

    Receive email updates from our team

    Subscribe